Alzheimer's disease (AD) is characterized by core pathological mechanisms including amyloid-β plaque aggregation, cholinergic dysfunction, and neuronal apoptosis. Given the complex interplay of these pathways, combination therapies are emerging as more effective strategies than single-target approaches. The success of...
Yue Na, C. Liu, Xinming Bi et al.· Materials Today Bio· 0 citations
A theoretical framework for TCM polysaccharide intervention in AD via the gut–brain axis is provided and a pharmacological basis for developing natural product-based AD therapies is provided.
Jie Gao, Liheng Li, Qi Liu et al.· Molecules· 0 citations
This work overviews preclinical microneedle formulations and key signaling pathways, and establishes a matching framework linking therapeutic targets, drugs, and microneedle types that may guide the rational design and clinical translation of microneedle-mediated brain-targeted drug delivery systems.
Jia Li, Yu-Bo Wang, Xin Ma et al.· Nanomedicine: Nanotechnology...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.